| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |